AMECX | FAASX | AMECX / FAASX | |
Total Expense Ratio | 0.58 | 0.93 | 62% |
Annual Report Gross Expense Ratio | 0.58 | 0.93 | 62% |
Fund Existence | 52 years | 17 years | - |
Gain YTD | 14.558 | 13.798 | 106% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 138B | 7.3B | 1,892% |
Annual Yield % from dividends | 3.59 | 1.38 | 260% |
Returns for 1 year | 9.96 | 8.49 | 117% |
Returns for 3 years | 40.41 | 45.18 | 89% |
Returns for 5 years | 44.82 | 41.44 | 108% |
Returns for 10 years | 66.69 | 78.63 | 85% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 39.57 | 0.43 | +1.10% |
Eventide Healthcare & Life Sciences A | |||
GMCUX | 17.02 | 0.17 | +1.01% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
FCVIX | 20.26 | 0.20 | +1.00% |
Fidelity Advisor Small Cap Value I | |||
HFCGX | 32.81 | 0.30 | +0.92% |
Hennessy Cornerstone Growth Investor | |||
RWEBX | 66.35 | 0.41 | +0.62% |
American Funds Washington Mutual R2E |